Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07298941 · ClinicalTrials.gov registry record · Phase 2
Resilience Enhancement Following Sleep Treatment
A Phase 2 study of Insomnia and Chronic Low Back Pain (CLBP), sponsored by University of Virginia.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT07298941 is a Phase 2 study of Insomnia and Chronic Low Back Pain (CLBP) that is actively recruiting participants, run by University of Virginia. The registered enrollment target is 300 participants, above the 168-participant average among 151 other Insomnia trials with a reported enrollment target (79% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07298941, a Phase 2 study of Insomnia and Chronic Low Back Pain (CLBP), is actively recruiting participants, sponsored by University of Virginia.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to evaluate the efficacy of an adaptive intervention targeting both insomnia and positive affect in improving pain outcomes for adults with chronic low back pain (cLBP) and comorbid insomnia. Specifically, the study tests whether augmenting a cognitive behavioral therapy for insomnia (CBTi) program with a meditation intervention (Savoring Meditation) or a Pain Education intervention will result in greater reductions in pain intensity. Secondary objectives include evaluating improvements in insomnia severity, positive and negative affect, and overall quality of life.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive-behavioral therapy for insomnia (CBTi)
- BEHAVIORAL CBTi + Savoring Meditation
- BEHAVIORAL CBTi + Pain Education
Study Locations (1)
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2025-12-16 |
| Est. Completion | 2030-04-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07298941
The ClinicalTrials.gov registry entry for NCT07298941 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 168-participant average among 151 other Insomnia trials with a reported enrollment target (79% higher). The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Insomnia appearing as the primary indexed condition, and to 3 interventions - of which Cognitive-behavioral therapy for insomnia (CBTi) is the first listed.
NCT07298941 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT07298941 about?
NCT07298941 is a clinical study titled "Resilience Enhancement Following Sleep Treatment". The primary objective of this study is to evaluate the efficacy of an adaptive intervention targeting both insomnia and positive affect in improving pain outcomes for adults with chronic low back pain (cLBP) and comorbid insomnia. Specifically, the study tests whether augmenting a cognitive behavior...
What is the current status of trial NCT07298941?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 300 participants. The study started on 2025-12-16. Estimated completion is 2030-04-30.
What conditions does trial NCT07298941 study?
This clinical trial studies the following conditions: Insomnia, Chronic Low Back Pain (CLBP).
What interventions are being tested in trial NCT07298941?
The interventions under investigation include: Cognitive-behavioral therapy for insomnia (CBTi) (BEHAVIORAL), CBTi + Savoring Meditation (BEHAVIORAL), CBTi + Pain Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT07298941?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07298941 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insomnia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
Pimavanserin for Insomnia in Veterans With PTSD
RECRUITING · Phase 2
-
Neural Mechanisms Connecting Deficient Sleep and Smoking Relapse
RECRUITING · Phase 2
-
Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND)
RECRUITING · Phase 2
-
Suvorexant for Treatment of AUD and PTSD
RECRUITING · Phase 2
-
Efficacy of Cognitive Behavioral Therapy for Insomnia to Treat Insomnia Symptoms in Individuals With Multiple Sclerosis
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.